Granules India may see buying interest

Granules India, after market hours, said the US Food and Drug Administration had concluded its inspection at the company’s Gagillapur unit in Telangana last week and did not make any observations on the facility. The unit manufactures pharmaceutical formulation ingredients and finished dosages. The inspection took place in the wake of the filing of an ANDA from the unit. Shares could react positively to the development.